{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-052952","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.497862+00:00","generated_at":"2026-05-16T18:45:36.474492+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nutex Health restates Q1 2025: revenue $211.8M, net income $21.2M, diluted EPS $3.33","bullets":["Total revenue $211.8M, up 214% YoY from $67.5M.","Net income attributable to Nutex $21.2M vs net loss $0.4M in Q1 2024.","Diluted EPS $3.33 vs loss per share $0.08.","Adjusted EBITDA $72.8M vs $(0.4)M prior year.","Net cash from operating activities of $51.0M for Q1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-052952","json":"https://secwatch.observer/filing/0001628280-25-052952.json","markdown":"https://secwatch.observer/filing/0001628280-25-052952.md","text":"https://secwatch.observer/filing/0001628280-25-052952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000162828025052952/0001628280-25-052952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000162828025052952/nutx-20251118.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:45:36.474492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}